AML-2: CD80/IL-2 Immune Gene Therapy for Poor Prognosis Acute Myeloid Leukaemia

Project: Research

Project Details

StatusFinished
Effective start/end date1/09/201931/08/2022

Funding

  • J P Moulton Charitable Foundation: £593,964.00